Celgene Has Upside Potential (CELG)

Celgene (NASDAQ: CELG) stock still has growth potential left in it. The stock has notched up 45 percent over the last 12 months. The company is growing its profits. Barron’s reported that the stock is currently trading at 22 times earnings, but still it has the potential to grow 30% or more.

Gene Mack, an analyst with Soleil Securities, told Barron’s, “Celgene's (CELG) fundamentals are going for cheap, This is a company that can grow earnings 25% annually over the next several years, and as they do that, there is sustainable upside to the stock price.”